News
The two largest health insurers in Massachusetts are effectively telling the drug companies that they may seek a rapidly ...
Weight loss medications can reduce the efficacy of oral contraceptives. What to know before taking drugs like Ozempic, ...
The GLP-1 arena has turned into a boxing match between heavyweights Novo Nordisk and Eli Lilly as the two pharma giants ...
Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this ...
GLP-1 drugs like Ozempic® and Zepbound® have gained significant attention for treating both diabetes and assisting with weight loss.
See how GLP-1 drugs reduce heart and kidney complications in MGUS and diabetes—explore the clinical evidence. Keep reading!
Rybelsus, the oral form of Semaglutide launched by Novo Nordisk in January 2022, has grown from Rs 26 crore to Rs 412 crore, ...
Does using Ozempic cause brain fog? It depends on who you ask. This article takes a closer look at what’s going on with ...
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...
The medications still amount to around $500 per month for those without insurance—out of reach for many patients. And even ...
As summer began and temperatures rose in June, so too did TV ad spending for Novo Nordisk’s Wegovy. | As summer began and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results